Pathology report showed a fully resected metastasis of the known poorly differentiated adenocarcinoma with a significant change in programmed death-ligand 1 (PD-L1) status (synchronous brain metastasis with moderate PD-L1 expression, metachronous brain metastasis with low PD-L1 expression). The gene discussed is CD274; the disease is adenocarcinoma.